• Home

  • Documents

  • Preliminary safety and activity in a first-in-human Phase ... · PDF...
17

Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30

  • Upload
    lamnhi

  • View
    214

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 2: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 3: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 4: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 5: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 6: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 7: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 8: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 9: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 10: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 11: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 12: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 13: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 14: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 15: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 16: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30
Page 17: Preliminary safety and activity in a first-in-human Phase ... · PDF file01.12.2016 · BLU-285 is an investigational agent currently in development by Blueprint ... SD 90 135 30 30

Investigational Product Accountability Log: Stock Record

Investigational Product Accountability Log: Stock Record

Documents
KCCOP Guidelines for Investigational Drug Management

KCCOP Guidelines for Investigational Drug Management

Documents
Webinar presentation: Manufacturing investigational

Webinar presentation: Manufacturing investigational

Documents
Investigational Drug Steering Committee Update

Investigational Drug Steering Committee Update

Documents
Investigational New drug application [INDA]

Investigational New drug application [INDA]

Health & Medicine
GAO-17-564, INVESTIGATIONAL NEW DRUGS:: FDA …Appendix I Form FDA 1571, Investigational New Drug Application 36 Appendix II Form FDA 3926, Individual Patient Expanded Access Investigational

GAO-17-564, INVESTIGATIONAL NEW DRUGS:: FDA …Appendix I Form FDA 1571, Investigational New Drug Application 36 Appendix II Form FDA 3926, Individual Patient Expanded Access Investigational

Documents
Investigational Plan & Clinical Study Protocol

Investigational Plan & Clinical Study Protocol

Documents
Investigational Report 514, December 2004

Investigational Report 514, December 2004

Documents
*Based on Medical Policy, potential investigational codes ...€¦ · Edit Type. Comment *Based on Medical Policy, potential investigational codes may be denied as investigational

*Based on Medical Policy, potential investigational codes ...€¦ · Edit Type. Comment *Based on Medical Policy, potential investigational codes may be denied as investigational

Documents
Investigational Chemotherapy and Novel Pharmacokinetics

Investigational Chemotherapy and Novel Pharmacokinetics

Documents
Investigational new drug application

Investigational new drug application

Education
Investigational Drugs

Investigational Drugs

Documents
INDEPENDENT INVESTIGATIONAL REVIEW BOARD INC

INDEPENDENT INVESTIGATIONAL REVIEW BOARD INC

Documents
(Investigational Medicinal Products) – MIA(IMP)

(Investigational Medicinal Products) – MIA(IMP)

Documents
EASL 2015. HCV Investigational Agents

EASL 2015. HCV Investigational Agents

Health & Medicine
Investigational Drugs: Issued: 5/1991 Investigational ... · PDF file4. Dispensing of investigational drugs and biologics must meet all safety requirements provided by California Pharmacy

Investigational Drugs: Issued: 5/1991 Investigational ... · PDF file4. Dispensing of investigational drugs and biologics must meet all safety requirements provided by California Pharmacy

Documents
Investigational Antiretroviral Drugs and Strategies

Investigational Antiretroviral Drugs and Strategies

Documents
CLINICAL INVESTIGATIONAL PLAN 11-512 Cardiovascular

CLINICAL INVESTIGATIONAL PLAN 11-512 Cardiovascular

Documents
Investigational Device Exemption (IDE) Overview

Investigational Device Exemption (IDE) Overview

Documents
Clinical, Cosmetic and Investigational Dermatology

Clinical, Cosmetic and Investigational Dermatology

Documents
Clinical Edits by Code List Complete List Applies to All ......0102T Extracorp Shockwv Tx,anesth Investigational Denial Always considered investigational; investigational services

Clinical Edits by Code List Complete List Applies to All ......0102T Extracorp Shockwv Tx,anesth Investigational Denial Always considered investigational; investigational services

Documents
Clinical, Cosmetic and Investigational Dermatology Dovepress

Clinical, Cosmetic and Investigational Dermatology Dovepress

Documents
Clinical Edits by Code List Complete List Applies to All ... … · 0011M Onc prstate cancer mrna 12 gen alg Investigational Denial; Always considered investigational; investigational

Clinical Edits by Code List Complete List Applies to All ... … · 0011M Onc prstate cancer mrna 12 gen alg Investigational Denial; Always considered investigational; investigational

Documents
Immunotoxicology Evaluation of Investigational New Drugs

Immunotoxicology Evaluation of Investigational New Drugs

Documents
Demers Investigational

Demers Investigational

Documents
InSpace™ Clinical Investigational Plan

InSpace™ Clinical Investigational Plan

Documents
INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER

INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER

Documents
The Investigational Medicinal Product Dossier

The Investigational Medicinal Product Dossier

Documents
A Subcutaneously Administered Investigational RNAi ... · A Subcutaneously Administered Investigational RNAi Therapeutic ... • Concomitant quantitative bone marrow failure in ~50%

A Subcutaneously Administered Investigational RNAi ... · A Subcutaneously Administered Investigational RNAi Therapeutic ... • Concomitant quantitative bone marrow failure in ~50%

Documents
Investigational New Drug Applications (INDs) — Determining

Investigational New Drug Applications (INDs) — Determining

Documents